We conclude that PLK1 inhibition blocks cell cycle progression in neuroblastic cells by blocking PLK1 canonical regulatory function at the G2/M transition as well as cancer cell-specific blockage of G1/S transition occurring presumably via de-repression of RB1-associated gene expression. The gene discussed is RB1; the disease is cancer.